- Home
- ASGN vs SRPT Comparison
ASGN vs SRPT Comparison
Compare ASGN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- SRPT
- Stock Information
- Founded
- ASGN 1985
- SRPT 1980
- Country
- ASGN United States
- SRPT United States
- Employees
- ASGN N/A
- SRPT N/A
- Industry
- ASGN Professional Services
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- SRPT Health Care
- Exchange
- ASGN Nasdaq
- SRPT Nasdaq
- Market Cap
- ASGN 2.3B
- SRPT 2.0B
- IPO Year
- ASGN 1992
- SRPT 1997
- Fundamental
- Price
- ASGN $53.06
- SRPT $18.71
- Analyst Decision
- ASGN Hold
- SRPT Hold
- Analyst Count
- ASGN 6
- SRPT 30
- Target Price
- ASGN $61.67
- SRPT $44.37
- AVG Volume (30 Days)
- ASGN 464.9K
- SRPT 9.0M
- Earning Date
- ASGN 10-22-2025
- SRPT 08-06-2025
- Dividend Yield
- ASGN N/A
- SRPT N/A
- EPS Growth
- ASGN N/A
- SRPT N/A
- EPS
- ASGN 3.15
- SRPT N/A
- Revenue
- ASGN $4,004,900,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- ASGN N/A
- SRPT $9.41
- Revenue Next Year
- ASGN $2.42
- SRPT N/A
- P/E Ratio
- ASGN $16.62
- SRPT N/A
- Revenue Growth
- ASGN N/A
- SRPT 64.89
- 52 Week Low
- ASGN $46.64
- SRPT $10.42
- 52 Week High
- ASGN $101.66
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- ASGN 53.24
- SRPT 49.39
- Support Level
- ASGN $51.94
- SRPT $17.95
- Resistance Level
- ASGN $54.26
- SRPT $19.61
- Average True Range (ATR)
- ASGN 1.61
- SRPT 1.11
- MACD
- ASGN 0.03
- SRPT -0.04
- Stochastic Oscillator
- ASGN 59.07
- SRPT 25.45
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.